Allen Moseley joined Noro-Moseley Partners in 1998 and leads the firm’s healthcare practice, focused primarily on healthcare information technology and healthcare services. Over his 20-year career at NMP, Moseley has invested in several sectors of the healthcare market, including payer- and provider-facing technologies and tech-enabled service platforms, as well as healthcare service companies. He currently represents NMP on the boards of Elligo Health Research, NovuHealth, Pure Life Renal, and Streamline Health. Prior to joining NMP, Moseley was in the corporate finance group at the Robinson-Humphrey Co., an investment banking firm now owned by SunTrust Banks. Education: University of North Carolina at Chapel Hill, Harvard Business School (MBA)